Objectives: Evaluating locoregional extension of endometrial cancer is a key step in initial patient management. This study was undertaken to evaluate the feasibility of fusion imaging -a combination of magnetic resonance imaging (MRI) with real-time high-resolution ultrasound (US) -to diagnose endometrial cancer and extension. Methods: This prospective bi-centre study included 29 women with an endometrial cancer between 2013 and 2017. All women underwent a 1,5 Tesla MRI, with different sequences included a T2 MRI sequence. The volume dataset was loaded into the US system. Then, a manual registration of the live endovaginal US (6-12MHz) image and fusion imaging examination was record. The results of the 3 imaging techniques were compared with the reference diagnostic, which is post operative histological FIGO staging. Results: Endometrial cancer and its extension was diagnosed on T2 MRI by the tumour's hypersignal and the hypointense rim disappearance between the myometrium and the endometrium.
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Fusion imaging could diagnose endometrial tumour toward the hyperechogenic and heterogenous thickening or mass. Colour Doppler mode in fusion imaging, could help to describe hypervascularisation in myometrium invasion, and visualisation of a vascular bridge in isthmic invasion. Fusion imaging improve the rate of agreement with the final histological diagnostic to 70%, instead of 37% for US, and 50% for MRI. Myometrial invasion was being better diagnosed by fusion than MRI and US. Sensibility was respectively 85%, 60% and 40%. Likewise, negative predictive value was 60% for MRI, 50% for US, and 85% for fusion imaging.
Conclusions: These results demonstrate that fusion imaging could be a complementary technique for MRI to enhance diagnostic performance for endometrial cancer lesions. Fusion imaging could precise tumoural extension, therefore optimise patient with endometrial cancer management.
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Objectives To evaluate accuracy of risk of malignancy index (RMI), International Ovarian Tumour Analysis (IOTA) models: LR2, ADNEX, Simple Rules (SR), and subjective assessment to diagnose colon cancer metastases in the adnexa. Methods: From a group of consecutive patients undergoing surgery for pelvic mass, 15 had secondary malignancy in ovaries from colon cancer. Before surgery all underwent standardised transvaginal and abdominal ultrasound examination with predefined definitions (images and videos stored) so to calculate RMI, LR2, ADNEX, SR. A subjective assessment was considered to discriminate between malignant and benign lesion in a 6 point score (not primary vs. secondary cancer in ovaries). The carcinoembrionic antigen (CEA) was available in patients previously treated for colon cancer. Results: High RMI was assessed in 14 patients. Tumours were classified as malignant (n=13) or inconclusive (n=2) with IOTA-SR. Median value of LR2 was 76.3% (range: 36.3-91.2). Median values of ADNEX model calculations were as follows: risk of malignancy-85.2%, risk of metastatic cancer-5.1%, risk of stage II-IV ovarian cancer (OC)-38.9%, risk of stage I OC -17.8%. In subjective assessment 14 patients were suspected for malignancy. Papillary structures were recorded in 9 patients (4 cases had 3 and more; 4 tumours had papillations growing from septa). There were 13 multilocular tumours. Among 8 patients who had undergone surgery and chemotherapy for colon cancer before recurrence in ovaries, the CEA median was 3.25ng/ml (range: 0.3-9.4) and ADNEX model risk of metastasis 4.5%. Median concentration of cancer antigen 125 was 168 U/ml (20-995). Conclusions: There is high accuracy of risk prediction models and subjective assessment to define colon cancer metastasis in ovaries as malignant. However, there is no reliable tool to discriminate secondary from primary ovarian cancer, even in a group of patients previously treated for bowel cancer.
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